BIO CEO & Investor Conference 2020
Webcast: Rezolute's Keith Vendola Presents - Rezolute Initiates Phase 2b Clinical Trial of Lead Candidate RZ358 in Congenital Hyperinsulinism
Webcast: Rezolute's Keith Vendola Presents - Rezolute Initiates Phase 2b Clinical Trial of Lead Candidate RZ358 in Congenital Hyperinsulinism